Merck
MRK
#48
Rank
A$457.72 B
Marketcap
A$185.33
Share price
0.32%
Change (1 day)
53.59%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$5.51

According to Merck's latest financial reports the company's current EPS (TTM) is A$5.09. In 2025 the company made an earnings per share (EPS) of A$10.41 an increase over its 2024 EPS that were of A$9.62.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.51-47.01%
2025A$10.418.15%
2024A$9.624308.46%
2023A$0.22-97.32%
2022A$8.1610.92%
2021A$7.3584.68%
2020A$3.98-27.2%
2019A$5.4763.44%
2018A$3.35151.11%
2017A$1.33-54.58%
2016A$2.9330.21%
2015A$2.25-61.99%
2014A$5.93180.51%
2013A$2.11-31.82%
2012A$3.106.62%
2011A$2.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.43 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.99 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.86-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.14 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.18 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.61 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.64-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.07-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.53 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.95-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel